29.04.2024 15:04:23 - dpa-AFX: *FDA OKS ABBOTT'S ESPRIT BTK EVEROLIMUS ELUTING RESORBABLE SCAFFOLD SYSTEM FOR CHRONIC LIMB-THREATENING ISCHEMIA

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Abbott Laboratories 850103 NYSE 101,270 09.07.24 20:35:20 -0,850 -0,83% 101,260 101,280 103,780 102,120

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH